Skip to main content

Table 3 A multivariate analysis for survival after the first recurrence

From: The mode of progressive disease affects the prognosis of patients with metastatic breast cancer

Factors

Hazard ratio

95% CI

p value

New lesions at second chemotherapy

1.02

0.54–1.93

0.95

ER (+)

0.28

0.16–0.48

< 0.01

Targeted therapy alone

0.27

0.12–0.62

< 0.01

Eribulin administration

0.49

0.24–0.99

< 0.05

Visceral metastasis at first recurrence

1.10

0.70–1.73

0.68

  1. ER: estrogen receptor